1.2022 Seoul Consensus on Clinical Practice Guidelines for Functional Constipation
Young Sin CHO ; Yoo Jin LEE ; Jeong Eun SHIN ; Hye-Kyung JUNG ; Seon-Young PARK ; Seung Joo KANG ; Kyung Ho SONG ; Jung-Wook KIM ; Hyun Chul LIM ; Hee Sun PARK ; Seong-Jung KIM ; Ra Ri CHA ; Ki Bae BANG ; Chang Seok BANG ; Sung Kyun YIM ; Seung-Bum RYOO ; Bong Hyeon KYE ; Woong Bae JI ; Miyoung CHOI ; In-Kyung SUNG ; Suck Chei CHOI ;
Journal of Neurogastroenterology and Motility 2023;29(3):271-305
Chronic constipation is one of the most common digestive diseases encountered in clinical practice. Constipation manifests as a variety of symptoms, such as infrequent bowel movements, hard stools, feeling of incomplete evacuation, straining at defecation, a sense of anorectal blockage during defecation, and use of digital maneuvers to assist defecation. During the diagnosis of chronic constipation, the Bristol Stool Form Scale, colonoscopy, and a digital rectal examination are useful for objective symptom evaluation and differential diagnosis of secondary constipation. Physiological tests for functional constipation have complementary roles and are recommended for patients who have failed to respond to treatment with available laxatives and those who are strongly suspected of having a defecatory disorder. As new evidence on the diagnosis and management of functional constipation emerged, the need to revise the previous guideline was suggested. Therefore, these evidence-based guidelines have proposed recommendations developed using a systematic review and meta-analysis of the treatment options available for functional constipation. The benefits and cautions of new pharmacological agents (such as lubiprostone and linaclotide) and conventional laxatives have been described through a meta-analysis. The guidelines consist of 34 recommendations, including 3 concerning the definition and epidemiology of functional constipation, 9 regarding diagnoses, and 22 regarding managements. Clinicians (including primary physicians, general health professionals, medical students, residents, and other healthcare professionals) and patients can refer to these guidelines to make informed decisions regarding the management of functional constipation.
2.Bee venom phospholipase A2 ameliorates motor dysfunction and modulates microglia activation in Parkinson's disease alpha-synuclein transgenic mice.
Minsook YE ; Hwan Suck CHUNG ; Chanju LEE ; Joo Hyun SONG ; Insop SHIM ; Youn Sub KIM ; Hyunsu BAE
Experimental & Molecular Medicine 2016;48(7):e244-
α-Synuclein (α-Syn) has a critical role in microglia-mediated neuroinflammation, which leads to the development of Parkinson's disease (PD). Recent studies have shown that bee venom (BV) has beneficial effects on PD symptoms in human patients or 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxin-induced PD mice. This study investigated whether treatment with BV-derived phospholipase A2 (bvPLA2) would improve the motor dysfunction and pathological features of PD in human A53T α-Syn mutant transgenic (A53T Tg) mice. The motor dysfunction of A53T Tg mice was assessed using the pole test. The levels of α-Syn, microglia and the M1/M2 phenotype in the spinal cord were evaluated by immunofluorescence. bvPLA2 treatment significantly ameliorated motor dysfunction in A53T Tg mice. In addition, bvPLA2 significantly reduced the expression of α-Syn, the activation and numbers of microglia, and the ratio of M1/M2 in A53T Tg mice. These results suggest that bvPLA2 could be a promising treatment option for PD.
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
;
alpha-Synuclein*
;
Animals
;
Bee Venoms*
;
Bees*
;
Fluorescent Antibody Technique
;
Humans
;
Mice
;
Mice, Transgenic*
;
Microglia*
;
Parkinson Disease*
;
Phenotype
;
Phospholipases A2*
;
Phospholipases*
;
Spinal Cord
3.Efficacy and safety of entecavir plus carnitine complex (GODEX(R)) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study.
Dae Won JUN ; Byung Ik KIM ; Yong Kyun CHO ; Hong Ju KIM ; Young Oh KWON ; Soo Young PARK ; Sang Young HAN ; Yang Hyun BAEK ; Yong Jin JUNG ; Hwi Young KIM ; Won KIM ; Jeong HEO ; Hyun Young WOO ; Seong Gyu HWANG ; Kyu Sung RIM ; Jong Young CHOI ; Si Hyun BAE ; Young Sang LEE ; Young Suck LIM ; Jae Youn CHEONG ; Sung Won CHO ; Byung Seok LEE ; Seok Hyun KIM ; Joo Hyun SOHN ; Tae Yeob KIM ; Yong Han PAIK ; Ja Kyung KIM ; Kwan Sik LEE
Clinical and Molecular Hepatology 2013;19(2):165-172
BACKGROUND/AIMS: Carnitine and vitamin complex (Godex(R)) is widely used in patients with chronic liver disease who show elevated liver enzyme in South Korea. The purpose of this study is to identify the efficacy and safety of carnitine from entecavir combination therapy in Alanine aminotransferase (ALT) elevated Chronic Hepatitis B (CHB) patients. METHODS: 130 treatment-naive patients with CHB were enrolled from 13 sites. The patients were randomly selected to the entecavir and the complex of entecavir and carnitine. The primary endpoint of the study is ALT normalization level after 12 months. RESULTS: Among the 130 patients, 119 patients completed the study treatment. The ALT normalization at 3 months was 58.9% for the monotherapy and 95.2% for the combination therapy (P<0.0001). ALT normalization rate at 12 months was 85.7% for the monotherapy and 100% for the combination group (P=0.0019). The rate of less than HBV DNA 300 copies/mL at 12 months was not statistically significant (P=0.5318) 75.9% for the monotherapy, 70.7% for the combination and it was. Quantification of HBsAg level was not different from the monotherapy to combination at 12 months. Changes of ELISPOT value to evaluate the INF-gamma secretion by HBsAg showed the increasing trend of combination therapy compare to mono-treatment. CONCLUSIONS: ALT normalization rate was higher in carnitine complex combination group than entecavir group in CHB. Combination group was faster than entecavir mono-treatment group on ALT normalization rate. HBV DNA normalization rate and the serum HBV-DNA level were not changed by carnitine complex treatment.
Adult
;
Alanine Transaminase/blood
;
Antiviral Agents/*therapeutic use
;
Carnitine/*therapeutic use
;
DNA, Viral/analysis
;
Drug Therapy, Combination
;
Enzyme-Linked Immunospot Assay
;
Female
;
Guanine/*analogs & derivatives/therapeutic use
;
Hepatitis B Surface Antigens/blood
;
Hepatitis B e Antigens/blood
;
Hepatitis B virus/genetics
;
Hepatitis B, Chronic/*drug therapy
;
Humans
;
Interferon-gamma/metabolism
;
Male
;
Middle Aged
;
Mitochondria/physiology
;
Treatment Outcome
;
Vitamin B Complex/*therapeutic use
4.Neuroprotective Effects of AMP-Activated Protein Kinase on Scopolamine Induced Memory Impairment.
Soo Jeong KIM ; Jun Ho LEE ; Hwan Suck CHUNG ; Joo Hyun SONG ; Joohun HA ; Hyunsu BAE
The Korean Journal of Physiology and Pharmacology 2013;17(4):331-338
AMP-activated protein kinase (AMPK), an important regulator of energy metabolism, is activated in response to cellular stress when intracellular levels of AMP increase. We investigated the neuroprotective effects of AMPK against scopolamine-induced memory impairment in vivo and glutamate-induced cytotoxicity in vitro. An adenovirus expressing AMPK wild type alpha subunit (WT) or a dominant negative form (DN) was injected into the hippocampus of rats using a stereotaxic apparatus. The AMPK WT-injected rats showed significant reversal of the scopolamine induced cognitive deficit as evaluated by escape latency in the Morris water maze. In addition, they showed enhanced acetylcholinesterase (AChE)-reactive neurons in the hippocampus, implying increased cholinergic activity in response to AMPK. We also studied the cellular mechanism by which AMPK protects against glutamate-induced cell death in primary cultured rat hippocampal neurons. We further demonstrated that AMPK WT-infected cells increased cell viability and reduced Annexin V positive hippocampal neurons. Western blot analysis indicated that AMPK WT-infected cells reduced the expression of Bax and had no effects on Bcl-2, which resulted in a decreased Bax/Bcl-2 ratio. These data suggest that AMPK is a useful cognitive impairment treatment target, and that its beneficial effects are mediated via the protective capacity of hippocampal neurons.
Acetylcholinesterase
;
Adenoviridae
;
AMP-Activated Protein Kinases
;
Animals
;
Annexin A5
;
Apoptosis
;
Blotting, Western
;
Cell Death
;
Cell Survival
;
Energy Metabolism
;
Hippocampus
;
Memory
;
Neurons
;
Neuroprotective Agents
;
Rats
;
Scopolamine Hydrobromide
;
United Nations
5.Life-Threatening Simultaneous Bilateral Spontaneous Tension Pneumothorax: A case report.
Taegeun RIM ; Joo Suck BAE ; Yong Soo YUK
The Korean Journal of Thoracic and Cardiovascular Surgery 2011;44(3):253-256
Spontaneous pneumothorax is a common clinical problem in emergency care. However, the overall incidences of primary spontaneous pneumothorax has been reported from as low as 1.4% to 7.6%. The clinical findings of simultaneous bilateral spontaneous pneumothorax can be variable. Clinical presentation is variable, ranging from mild dyspnea to tension pneumothorax. Bilateral tension pneumothorax can defined as cases where no tracheal deviation is detected in chest X-ray, and symptoms may be equal bilaterally. Herein, we present a case with simultaneous bilateral tension pneumothorax, severely deteriorated (i.e. with loss of consciousness, cyanosis, and hemodynamically unstable), that was successfully treated with immediate large-size needle decompression.
Cyanosis
;
Decompression
;
Dyspnea
;
Emergency Medical Services
;
Incidence
;
Needles
;
Pneumothorax
;
Thorax
;
Unconsciousness
6.A Case of Esophageal Carcinoma after an Esophageal Reconstruction Operation for Sulfuric Acid Injury.
Eun Seo PARK ; Suck Ho LEE ; Chang Kyun LEE ; Bo Yong JUNG ; Il Kwun CHUNG ; Sun Joo KIM ; Sang Byung BAE ; Ji Hye LEE
Korean Journal of Gastrointestinal Endoscopy 2010;41(4):214-218
Patients with corrosive esophageal strictures have a high risk of developing carcinoma of the esophagus. For this reason, it is often recommended that resection of the esophagus should be considered for chronic caustic strictures in order to prevent the development of carcinoma. A 49-year-old woman who had undergone an esophagogastrectomy due to esophageal caustic stricture at the age of 23 was admitted with a 2-month history of dysphagia. Esophagoscopy showed a benign postoperative stricture in the remnant esophagus. After endoscopic balloon dilation of the stricture, which was about 5 cm in length, an ulcerative mass was noted distal to the stricture. This mass was diagnosed as squamous cell carcionoma. Nearly all the patients with corrosive carcinomas in the published literature had consumed an alkali drink, but our patient had a history of sulfuric acid ingestion.
Alkalies
;
Constriction, Pathologic
;
Deglutition Disorders
;
Eating
;
Esophageal Stenosis
;
Esophagoscopy
;
Esophagus
;
Female
;
Humans
;
Middle Aged
;
Sulfur
;
Sulfuric Acids
;
Ulcer
7.Annual Report on External Quality Assessment in Urinalysis in Korea (2009).
Kyung Dong KIM ; Sun Hoe KOO ; Eui Chong KIM ; Jung Mann KIM ; Jeong Ho KIM ; Jin Q KIM ; Dae Soo MOON ; Won Ki MIN ; Chang Ho JEON ; Sung Hoon PARK ; Jeonh Il KOO ; Myung Joo KIM ; Young Choel BAE ; Woon Heung SONG ; Kwang Ho CHO ; Sung Suck CHO
Journal of Laboratory Medicine and Quality Assurance 2010;32(1):69-93
Three external quality assesment trials which composed of 16 control materials(12 chemical materials and four sets of microscopic photograph of urinary sediment) for interlaboratory quality control assesment in urinalysis were performed with 796, 823, and 841 participants, in each, in the year of 2009. The response rate were 97.1% (796/820), 95.5% (823/862) and 97.1% (841/866), in the first, the second and the third trials, in each. The test items include pH, glucose, protein, ketone, bilirubin, blood, urobilinogen, nitrite, leukocyte estrase, specific gravity and four microscopic photographs of urinary sediment. The survey results are summarized as follows: 1. The chemical quality control test in urinalysis revealed generally good concordance. 2. The percentage of using urinalysis analyzer was slightly decreased as 82.3% and the distribution of using reagent strip was similar to the previous year. 3. The percentage of response rate of microscopic photographs of urinary sediment was 83.5% (702/841) and the percentage of good performance of these tests ware 83.6% to 99.1%.
Bilirubin
;
Equidae
;
Glucose
;
Hydrogen-Ion Concentration
;
Korea
;
Leukocytes
;
Quality Control
;
Reagent Strips
;
Specific Gravity
;
Urinalysis
;
Urobilinogen
8.Annual Report on External Quality Assessment in Urinalysis in Korea (2008).
Kyung Dong KIM ; Sun Hoe KOO ; Eui Chong KIM ; Jung Mann KIM ; Jeong Ho KIM ; Jin Q KIM ; Dae Soo MOON ; Won Ki MIN ; Chang Ho JEON ; Sung Hoon PARK ; Jeonh Il KOO ; Myung Joo KIM ; Young Choel BAE ; Woon Heung SONG ; Kwang Ho CHO ; Sung Suck CHO
Journal of Laboratory Medicine and Quality Assurance 2009;31(1):73-98
Three external quality assesment trials which composed of 16 control materials (12 chemical materials and four sets of microscopic photograph of urinary sediment) for interlaboratory quality control assesment in urinalysis were performed with 699, 718, and 732 participants, in each, in the year of 2008. The response rate were 95.4% (699/733), 96.6% (718/743) and 95.3% (732/767), in the first, the second and the third trials, in each. The test items include pH, glucose, protein, ketone, bilirubin, blood, urobilinogen, nitrite, leukocyte estrase, specific gravity and four microscopic photographs of urinary sediment. The survey results are summarized as follows: 1. The chemical quality control test in urinalysis revealed generally good concordance. 2. The percentage of using urinalysis analyzer was slightly decreased as 83.0% and the distribution of using reagent strip was similar to the previous year. 3. The percentage of response rate of microscopic photographs of urinary sediment was 81.3% (571/732) and the percentage of good performance of these tests ware 32.9% to 80.5%.
Bilirubin
;
Equidae
;
Glucose
;
Hydrogen-Ion Concentration
;
Korea
;
Leukocytes
;
Quality Control
;
Reagent Strips
;
Specific Gravity
;
Urinalysis
;
Urobilinogen
9.The actual condition of drug-resistant tuberculosis and treatment outcomes at a tuberculosis specialized hospital.
Sung Il CHOI ; Joong Ho BAE ; Suck Jun KONG ; Joo Hong PARK
Korean Journal of Medicine 2006;70(2):172-182
BACKGROUND: During the last decade, the reports of drug-resistant tuberculosis in Korea were not common. Therefore, we investigated the anti-tuberculosis drug resistance rate according to medical history and radiological findings, as well as the relationship between the drug resistance and treatment outcomes to provide guidelines for selection of drug regimen before drug sensitivity test. METHODS: The study population was composed of 745 hospitalized patients who received drug susceptibility test for M. tuberculosis and anti-tuberculosis chemotherapy for the last 5 years. RESULTS: The majority had resistance to at least one drug (91.3%; 3.8+/-2.6 drugs). Drug resistance rate of first line drugs was 25~55%; especially higher in retreatment cases and those with the cavity on chest X-ray. Drug resistance was not correlated with radiographic finding. The success rate for treatment was higher in new cases, patients with less severe disease status and those without cavity on chest X-ray. When new cases had no resistance to all of EHR (84.1%), the negative conversion rate by first line drugs was above 70~90%. For retreatment patients, the negative conversion rate was above 70% only when they were susceptible to all of EHR (31%). The relapse rate was 4~13%. CONCLUSIONS: Probably the prevalence of drug-resistant tuberculosis in Korea will be considerably high. The drug resistance and treatment outcome was affected more by history of previous medical treatment than radiological findings. The previous EHRZ regimen is very effective as the initial treatment in new case, but revised retreatment regimen composed of at least 4 drugs is needed in the previously treated patients.
Drug Resistance
;
Drug Therapy
;
Humans
;
Korea
;
Medical History Taking
;
Prevalence
;
Radiography, Thoracic
;
Recurrence
;
Retreatment
;
Thorax
;
Treatment Outcome
;
Tuberculosis*
;
Tuberculosis, Multidrug-Resistant*
10.The Usefulness of Positional Change in Endoscopic Hemostasis for Bleeding Dieulafoy's Lesion.
Jae Hak LEE ; Suck Ho LEE ; Won Yeop BAE ; Jeong Hoon PARK ; Do Hyun PARK ; Il Kwun CHUNG ; Sang Heum PARK ; Sun Joo KIM
Korean Journal of Gastrointestinal Endoscopy 2006;32(3):168-172
BACKGROUND/AIMS: Dieulafoy's lesion is a rare cause of massive upper gastrointestinal bleeding, most commonly in the proximal stomach. Although the mechanical hemostatic method has been widely used, it is difficult to access for complete application. This study evaluated the utility of a positional change in patients with a bleeding Dieulafoy's lesion. METHODS: Between January 2003 and March 2004, 15 patients with a bleeding Dieulafoy's lesion were randomly assigned to either a positional change group (right decubitus or supine, n=7) or a left decubitus group (n=8). The demographic characteristics, endoscopic variables, and clinical outcomes were analyzed. RESULTS: The patients' characteristics at entry were similar in both groups. Initial hemostasis was achieved in all patients. Recurrent bleeding developed in only one patients in the left decubitus group. The mean procedure time was significantly shorter in the positional change group than in the left decubitus group (4.5+/-3.4 min vs. 7.4+/-5.2 min, p<0.05). The ineffective hemoclip number (respectively, 0.3+/-0.1 vs. 1.4+/-1.2, p<0.05) was significantly different in the two groups. No major procedure-related complications occurred in the positional change group. CONCLUSIONS: Endoscopic hemostasis with a positional change is an effective and safe method for treating in a bleeding Dieulafoy's lesion.
Hemorrhage*
;
Hemostasis
;
Hemostasis, Endoscopic*
;
Humans
;
Stomach

Result Analysis
Print
Save
E-mail